In an interview with The Daily Beast, author Tom Shroder explains why psychedelics are so important to veterans, and the roadblocks researchers face getting it to them.
But with the widespread recreational use of LSD beginning the 1960s, came both fear from both the general public and the government. After 1970 (when LSD was put on the schedule 1 substance list) it wasn’t technically illegal to do research with psychedelics but rather virtually impossible, given the professional and regulatory hurdles.
More than 40 years later, the criminalization of Hofmann’s drug still persists. The means and approval to research the psychedelic on humans is few and far between. The freedom of sufferers who may benefit to access it is all but nonexistent.
Nowhere are the negative effects of psychedelics’ fate more pronounced than in the story of America’s veterans. Of the many illnesses for which the psychedelic-assisted therapy showed promise, Post-Traumatic Stress Disorder was one of the most profound.
An estimated 500,000 Iraq-Afghanistan military veterans are suffering from PTSD, an excruciating illness that is believed to fuel the estimated 20 suicides that result from that demographic per day. In FDA sanctioned studies using MDMA-assisted therapy to treat veterans with PTSD, the success rate has been astounding. Why has no one noticed? Read the rest of this entry »